多家北交所公司业绩预喜！次新股蘅东光，盈利或翻倍增长！

Core Viewpoint - The company Hengtong Guang is expected to see a significant increase in net profit for 2025, with projections indicating a growth of 82.95% to 110.05% year-on-year, reaching between 270 million to 310 million yuan [1][4][5] Group 1: Company Performance - Hengtong Guang's first annual performance forecast since its listing on the Beijing Stock Exchange indicates a strong financial outlook [1][4] - The company focuses on the research, manufacturing, and sales of passive optical device products in the optical communication field, with key products including optical fiber connectors and passive optical modules [5][6] - The anticipated profit growth is attributed to the rapid increase in AI computing power demand and accelerated data center construction, leading to a sustained rise in global demand for passive optical device products [2][5] Group 2: Market and Competitive Position - The company is actively developing global markets and expanding its manufacturing capacity both domestically and internationally, which is expected to enhance product competitiveness [2][5] - Analysts suggest that with the release of production capacity from subsequent fundraising projects and the introduction of new products, Hengtong Guang's performance is likely to enter a rapid growth phase [2][5] - The company's price-to-earnings ratio is higher than the average of comparable companies, indicating a reasonable valuation, and there is optimism regarding the growth potential driven by major North American cloud service providers' capital expenditures [2][5] Group 3: Other Companies' Performance - Other companies such as Oufu Egg Industry and Shibi Bai are also forecasting significant profit increases for 2025, with Oufu Egg Industry projecting a net profit of 8 million to 9.2 million yuan, representing a year-on-year growth of 75.44% to 101.75% [6] - Shibi Bai expects to turn a profit with a projected net profit of 5 million to 6 million yuan for 2025 [6] - Conversely, Dayu Biological anticipates continued losses for 2025, with a projected net loss of 26 million to 30 million yuan, impacted by declining gross margins and high fixed costs [3][6]